Cancer clinical trials. A rational basis for use of historical controls.

[1]  R W Makuch,et al.  Sample size considerations for non-randomized comparative studies. , 1980, Journal of chronic diseases.

[2]  L Cranberg,et al.  For debate: Do retrospective controls make clinical trials "inherently fallacious?". , 1979, British medical journal.

[3]  J. Klein.  Medical Ethics and Controlled Clinical Trials , 1979, The Annals of otology, rhinology & laryngology. Supplement.

[4]  Gehan Ea.  Comparative clinical trials with historical controls: a statistician's view. , 1978 .

[5]  G. Hortobagyi,et al.  Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer , 1978, Cancer.

[6]  E. Gehan,et al.  Multidrug adjuvant chemotherapy for osteosarcoma: interim report of the Southwest Oncology Group Studies. , 1978, Cancer treatment reports.

[7]  L. Einhorn,et al.  Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. , 1977, Annals of internal medicine.

[8]  J. Minna,et al.  Intensive chemotherapy of small cell bronchogenic carcinoma. , 1977, Cancer treatment reports.

[9]  F. Cabanillas,et al.  Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphoma. , 1977, Blood.

[10]  G. Bonadonna,et al.  Combination chemotherapy as an adjuvant treatment in operable breast cancer. , 1976, The New England journal of medicine.

[11]  A. Feinstein.  xxxv. The persistent clinical failures and fallacies of the UGDP study , 1976 .

[12]  C. Redmond,et al.  1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. , 1975, The New England journal of medicine.

[13]  D. Johnson,et al.  Continuous intravenous bleomycin (NSC-125066) therapy with vinblastine (NSC-49842) in stage III testicular neoplasia. , 1975, Cancer chemotherapy reports.

[14]  N. Jaffe,et al.  Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. , 1974, The New England journal of medicine.

[15]  E. Gehan,et al.  Non-randomized controls in cancer clinical trials. , 1974, The New England journal of medicine.

[16]  E. Frei,et al.  Chemotherapy of malignant lymphoma with adriamycin. , 1973, Cancer research.

[17]  J. Sinkovics,et al.  Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide , 1972, Cancer.

[18]  J B Block,et al.  Controlled studies in clinical cancer research. , 1972, The New England journal of medicine.

[19]  Jung Sun Kim,et al.  Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer , 1972, Cancer.

[20]  V. Devita,et al.  Combination chemotherapy in the treatment of advanced Hodgkin's disease. , 1970, Annals of internal medicine.

[21]  J. Harris,et al.  Therapy for acute granulocytic leukemia. , 1967, Cancer research.

[22]  D. Burkitt.  Long‐term remissions following one and two‐dose chemotherapy for African lymphoma , 1967, Cancer.

[23]  H Atkins,et al.  Conduct of a controlled clinical trial. , 1966, British medical journal.

[24]  E. Freireich,et al.  RECENT ADVANCES IN ACUTE LEUKEMIA. , 1964, Progress in hematology.

[25]  J. Wolff,et al.  Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. , 1948, The New England journal of medicine.